Nadia Solovieff
Novartis (France)(FR)Novartis (United States)(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Lung Cancer Research Studies, Neuroendocrine Tumor Research Advances, Cancer Genomics and Diagnostics, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → A polygenic burden of rare disruptive mutations in schizophrenia(2014)1,439 cited
- → Pleiotropy in complex traits: challenges and strategies(2013)1,162 cited
- → Fetal hemoglobin in sickle cell anemia(2011)532 cited
- → Genetic Signatures of Exceptional Longevity in Humans(2012)461 cited
- → Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer(2019)407 cited
- → Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism(2016)275 cited
- → Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies(2021)149 cited
- → Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster(2009)141 cited
- → Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study(2016)132 cited